Dr. Marino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Avenue
Cleveland, OH 44106Phone+1 216-844-1636Fax+1 216-844-7783
Education & Training
- UPMC Medical EducationFellowship, Medical Toxicology (Emergency Medicine), 2017 - 2019
- UPMC Medical Education (Pittsburgh)Residency, Emergency Medicine, 2014 - 2017
- University of Pittsburgh School of MedicineClass of 2017
- University of Pittsburgh School of MedicineClass of 2014
Certifications & Licensure
- OH State Medical License 2019 - 2026
- PA State Medical License 2014 - 2024
- American Board of Emergency Medicine Emergency Medicine
- American Board of Emergency Medicine Medical Toxicology
- American Board of Preventive Medicine Addiction Medicine
Publications & Presentations
PubMed
- 16 citationsACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder.Ryan Marino, Jeanmarie Perrone, Lewis S. Nelson, Timothy J. Wiegand, Evan S. Schwarz
Journal of Medical Toxicology. 2019-10-01 - 28 citationsDo electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?Ryan T. Marino, Aaron Landau, Michael J. Lynch, Clifton W. Callaway, Brian Suffoletto
Addiction. 2019-09-01 - 157 citationsToll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosis.Matthew D. Neal, Chhinder P. Sodhi, Hongpeng Jia, Mitchell Dyer, Charlotte E. Egan
The Journal of Biological Chemistry. 2012-10-26
Authored Content
- When myths are more dangerous than reality: the falsehood of naloxone-induced aggression and assaultOctober 2019
- EMS data sharing to combat the opioid epidemicJune 2018
- Research Analysis: Conclusions about 'moral hazard' of naloxone not supported by methodologyMarch 2018
Press Mentions
- The New Longevity Treatment That Is Seducing Elite Athletes and CEOsNovember 10th, 2024
- Wide Availability of Naloxone and Education on Its Use Can Save Pediatric LivesOctober 9th, 2024
- A Closer Look at Medetomidine and Its 'Unusual' Patient PresentationsJune 22nd, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: